Compare Elder Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DR. REDDYS LAB ELDER PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -0.2 41.2 - View Chart
P/BV x 0.1 5.6 1.8% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DR. REDDYS LAB
Mar-20
ELDER PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3803,363 11.3%   
Low Rs1882,352 8.0%   
Sales per share (Unadj.) Rs491.21,054.2 46.6%  
Earnings per share (Unadj.) Rs-3.2121.9 -2.6%  
Cash flow per share (Unadj.) Rs14.4190.2 7.6%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs376.5938.7 40.1%  
Shares outstanding (eoy) m20.54166.17 12.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.62.7 21.3%   
Avg P/E ratio x-89.323.4 -380.9%  
P/CF ratio (eoy) x19.715.0 131.2%  
Price / Book Value ratio x0.83.0 24.8%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m5,833474,831 1.2%   
No. of employees `000NA21.7 0.0%   
Total wages/salary Rs m2,17933,802 6.4%   
Avg. sales/employee Rs ThNM8,091.0-  
Avg. wages/employee Rs ThNM1,561.3-  
Avg. net profit/employee Rs ThNM935.8-  
INCOME DATA
Net Sales Rs m10,089175,170 5.8%  
Other income Rs m2576,206 4.1%   
Total revenues Rs m10,346181,376 5.7%   
Gross profit Rs m-79224,421 -3.2%  
Depreciation Rs m36111,348 3.2%   
Interest Rs m2,756983 280.4%   
Profit before tax Rs m-3,65318,296 -20.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-1,403 -8.9%   
Profit after tax Rs m-6520,260 -0.3%  
Gross profit margin %-7.813.9 -56.3%  
Effective tax rate %-3.4-7.7 44.7%   
Net profit margin %-0.611.6 -5.6%  
BALANCE SHEET DATA
Current assets Rs m9,240125,991 7.3%   
Current liabilities Rs m9,99872,141 13.9%   
Net working cap to sales %-7.530.7 -24.4%  
Current ratio x0.91.7 52.9%  
Inventory Days Days4673 63.4%  
Debtors Days Days60105 57.2%  
Net fixed assets Rs m10,12483,854 12.1%   
Share capital Rs m206831 24.8%   
"Free" reserves Rs m5,582155,157 3.6%   
Net worth Rs m7,734155,988 5.0%   
Long term debt Rs m4,8891,304 374.9%   
Total assets Rs m22,882232,253 9.9%  
Interest coverage x-0.319.6 -1.7%   
Debt to equity ratio x0.60 7,562.4%  
Sales to assets ratio x0.40.8 58.5%   
Return on assets %11.89.1 128.6%  
Return on equity %-0.813.0 -6.5%  
Return on capital %22.312.6 176.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30784,193 0.4%   
Fx outflow Rs m12539,616 0.3%   
Net fx Rs m18144,577 0.4%   
CASH FLOW
From Operations Rs m11,75429,841 39.4%  
From Investments Rs m-561-4,923 11.4%  
From Financial Activity Rs m-6,762-25,159 26.9%  
Net Cashflow Rs m4,432-266 -1,666.1%  

Share Holding

Indian Promoters % 39.6 25.5 155.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 16.8 35.3 47.6%  
ADR/GDR % 0.0 18.5 -  
Free float % 36.1 15.3 235.9%  
Shareholders   16,479 75,885 21.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   CIPLA  PFIZER  NATCO PHARMA  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS